home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Nitric Oxide Inhalation Therapy for Preterm Found Questionable

 
  July, 14 2005 20:36
your information resource in human molecular genetics
 
     
Contrary to an earlier finding, inhaled nitric oxide therapy (a treatment for lung problems in premature infants) does not reduce the infant’s chances for death or further lung problems, according to a study by the National Institute of Child Health and Human Development of the National Institutes of Health. The study appears in the July 7 New England Journal of Medicine.

“Premature infants weighing less than 1500 grams should not receive inhaled nitric oxide therapy unless they are part of a research study,” said NICHD Director Duane Alexander, M.D.

Inhaled nitric oxide therapy is effective for treating full term infants with lung complications. In term infants, whose lungs are fully formed, these complications typically result from lung infection. For the treatment, nitric oxide gas is mixed with oxygen and given to an infant through a breathing apparatus. The treatment makes the blood vessels in the lung tissue relax, allowing the lungs to absorb oxygen more easily.

Because the treatment works well for term infants, researchers had been interested in its possible use to treat lung complications in preterm infants. Earlier research in preterm infants treated with inhaled nitric oxide therapy showed varied results.


Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.